Exploring how cancer cells use metabolism to grow and survive
Understanding the role of metabolism in cancer
This study is looking at how cancer cells use energy differently than normal cells, depending on the type of cancer and other factors, to find new ways to slow down or stop cancer growth and improve treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10899506 on NIH RePORTER |
What this research studies
This research investigates the unique metabolic needs of cancer cells compared to normal cells, focusing on how these needs vary by cancer type and are influenced by genetic and environmental factors. The approach involves identifying metabolic processes that limit cancer cell growth and understanding how these limitations can be overcome in a physiological context. By examining how cancer cells adapt their metabolism to support tumor growth, the research aims to uncover new insights that could lead to improved cancer treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with various types of cancer who are interested in understanding how their cancer's metabolism may influence treatment options.
Not a fit: Patients with non-cancerous conditions or those whose cancer has already reached an advanced stage with limited treatment options may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that target cancer metabolism, potentially improving treatment outcomes for patients.
How similar studies have performed: Previous research has shown promising results in targeting cancer metabolism, indicating that this approach has potential for significant advancements in cancer treatment.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Vander Heiden, Matthew G. — Massachusetts Institute of Technology
- Study coordinator: Vander Heiden, Matthew G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.